U-Chart Analysis:Mochida Pharmaceutical Co.,Ltd.:4534

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Mochida Pharmaceutical Co.,Ltd. Go to web site 4534 Medicals 東証プライム March 1, 2000 1963.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Mochida Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2024年3月期 Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2023年3月期 Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2022年3月期 Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2021年3月期 Mochida Pharmaceutical Co.,Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 33,290 47,010 48,415 54,487 53,291
Other Current AssetsHelp 83,372 70,369 73,033 64,306 63,603
Tangible Fixed AssetsHelp 15,874 15,049 14,528 13,299 13,851
Intangible Fixed AssetHelp 721 797 713 646 674
Investments and OthersHelp 25,543 25,606 26,450 29,053 26,069
Total AssetsHelp 158,800 158,831 163,139 161,791 157,488
Total Current LiabilitiesHelp 30,490 31,878 34,493 34,817 36,823
Total Long-term LiabilitiesHelp 343 178 0 0 0
Shareholder's EquityHelp 127,967 126,775 128,646 126,974 120,665
Total LiabilitiesHelp 158,800 158,831 163,139 161,791 157,488

Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2024年3月期 Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2023年3月期 Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2022年3月期 Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2021年3月期 Mochida Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 102,885 103,261 110,179 102,995 101,799
Total Sales 102,885 103,261 110,179 102,995 101,799
Cost of SalesHelp 50,815 48,146 50,626 48,203 49,882
Other Costs and RevenueHelp 47,523 48,466 48,984 46,204 47,319
Total CostsHelp 98,338 96,612 99,610 94,407 97,201
Net RevenueHelp 52,070 55,115 59,553 54,792 51,917
Earnings Before TaxHelp 6,160 9,044 14,591 11,900 6,273
Net IncomeHelp 4,547 6,649 10,569 8,588 4,598
Net Income 4,547 6,649 10,569 8,588 4,598

Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2024年3月期 Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2023年3月期 Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2022年3月期 Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2021年3月期 Mochida Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help -7,480 7,297 7,460 9,196 9,347
Investing Cash Flow(ICF)Help 74 -2,949 -2,007 -880 -1,760
Financing Cash FlowHelp -6,393 -6,884 -5,956 -5,112 -5,328
Exchange Difference of Cash and Cash EquivalentsHelp 79 32 31 -9 0
Net Increase and Decrease in Cash and Cash Equivalentsn -13,720 -2,504 -472 3,195 2,259

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Mochida Pharmaceutical Co.,Ltd.

Company where related level is highHelp

ASKA Pharmaceutical Co.,Ltd.
Nichi-Iko Pharmaceutical Co.,Ltd.
Modalis Therapeutics Corporation
KISSEI PHARMACEUTICAL CO.,LTD.
Nxera Pharma Co., Ltd.
NANO MRNA Co., Ltd.
MEDICAL & BIOLOGICAL LABORATORIES CO.
TAIKO PHARMACEUTICAL CO.,LTD.
HEALIOS K.K.
SSP CO.,LTD.